Blue chip stocks, thanks to their massive market capitalizations and deep liquidity, are a natural home for hedge funds and other large pools of institutional capital.
And since hedge funds are the putative smart money, who wouldn't want to know which blue chip stocks they're chasing with their capital?
True, hedge funds collectively have a rather poor long-term track record vs the broader market. It should also go without saying that not all blue chip stocks are created equal.
Yet there's still something irresistible about knowing what hedge funds have been up to. And even if the industry tends to generate disappointing returns, you've got to give it credit when credit is due.
Big-time investors are willing to pay up for complicated strategies offering exposure to uncorrelated assets. So it's not necessarily possible to tell from the outside if a hedge fund is providing its clients with the performance they expect.
It's also important to know that hedging strategies, by definition, limit upside when stocks are rising. That helps explain the industry's tendency to underperform in a bull market.
By the same token, however, hedging strategies limit downside when everything is selling off. And goodness knows investors saw plenty of red on their screens not that long ago.
"Despite the challenges from a bear market, hedge funds delivered resilient performance in 2022," notes Barclays Capital Solutions. "In a year when the MSCI World Index fell 18%, hedge funds captured only a fraction of the drawdown, thus offering the best downside protection since the dot-com bubble burst."
Blue chip stocks: timing is everything
So it should come as no surprise that a rough start to the year for equities has been good for hedge funds.
The Eurekahedge Hedge Fund Index delivered a total return (price change plus dividends) of almost 1% for the year to date through the end of April. The S&P 500, by comparison, generated a total return of -5% over the same span.
We won't know how hedge funds are dealing with the current market environment until they disclose their second quarter buys and sells in mid-August. But we do know what they were up to in Q1 thanks to a recent batch of regulatory filings.
As usual, hedge funds were heavily invested in most of the market's biggest and bluest of blue chip stocks – particularly Dow Jones stocks. Indeed, 11 of the 21 names listed below are components of the blue-chip barometer.
That's partly a function of Dow stocks' massive market caps and attendant liquidity, which, as noted, provide ample room for institutional investors to build or pare large stakes.
Big-name blue chip stocks also carry lower levels of reputational risk for professional money managers. It's a lot easier to justify holding a large stake in a Dow stock than a no-name small cap if restive clients start grumbling about their returns.
What's interesting about the latest data is how hedge funds collectively cut exposure to Magnificent 7 stocks.
Have a look at the chart below to see hedge funds' 21 top blue chip stock picks as of the end of Q1.
Company (ticker) |
Number of hedge funds holding |
Net change in hedge fund share ownership |
|---|---|---|
Microsoft (MSFT) |
858 |
-7,516,183 |
Amazon.com (AMZN) |
849 |
-26,222,214 |
Meta Platforms (META) |
763 |
-8,859,321 |
Alphabet (GOOGL) |
761 |
-29,519,651 |
Nvidia (NVDA) |
742 |
-77,313,073 |
Apple (AAPL) |
712 |
-7,264,565 |
Visa (V) |
612 |
-17,000,372 |
JPMorgan Chase (JPM) |
598 |
-17,533,108 |
Broadcom (AVGO) |
569 |
2,899,408 |
Berkshire Hathaway (BRK.B) |
566 |
495,167 |
Mastercard (MA) |
533 |
5,284,163 |
Eli Lilly (LLY) |
525 |
-1,263,230 |
UnitedHealth Group (UNH) |
523 |
3,530,266 |
Johnson & Johnson (JNJ) |
512 |
929,527 |
Exxon Mobil (XOM) |
511 |
11,507,300 |
Netflix (NFLX) |
496 |
-5,233,869 |
Home Depot (HD) |
492 |
-322,319 |
Taiwan Semiconductor Manufacturing (TSCM) |
487 |
-9,073,524 |
Walmart (WMT) |
486 |
-27,323,434 |
Procter & Gamble (PG) |
481 |
-8,078,196 |
Costco (COST) |
477 |
1,299,894 |
Source: WhaleWisdom and the Securities and Exchange Commission.
